Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
AFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.
MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.
NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
Abivax develops medicines that alter the body's natural immune system mechanisms.
Actithera is a molecular radiotherapeutic company that develops radioligand therapies.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
Moon Surgical develops a new category of robotic surgery that enhances existing clinical practice with collaborative and adaptive robotics.
Berry Street offers treatment for disordered eating, heart health, PCOD, liver disease, women's health, sports nutrition, and diabetes.
Leucid is progressing novel cart therapies that produce a better and more durable response.
Meiogenix is a biotechnology company that develops breeding technologies.
Elicit Plant is an agro-biotech company thatfocuses on enhancing the resilience of crops under drought conditions through natural processes.
Prometheus Materials develops bio-cement with zero carbon emissions to reduce the global CO2 emissions.
Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.
Micropep Technologies is a biotech company that focused on biological alternatives to agrochemicals.
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
Endoron Medical develops an endovascular suture, like device for an effective treatment of abdominal aortic aneurysm.
Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.
We provide simple, sophisticated respiratory solutions for post-ICU and home environments, eliminating unnecessary cost and complexity.
Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features.
BetterOmics is a SaaS platform that empowers professionals in the life sciences industry with cutting-edge AI and computational techniques.
l'école AI is a computer vision-focused development platform.
Sofinnova Partners has invested in 148 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 27 different industry categories.
Among tracked funding rounds, Abivax received $747.5M in a Post Ipo Equity round. Sofinnova Partners's total known invested capital is $6.3B.
Sofinnova Partners's average investment size is $48.1M across its portfolio of 148 companies.
Recent Sofinnova Partners portfolio additions include AFYREN, Hemab, Elevara Medicine, MISSION Therapeutics, NanoPhoria. These companies were founded in 2020 or later.